VeriMomБезопасен ли barley sh-oligopeptide-1 при беременности?
No evidence of reproductive or developmental hazard was identified in authoritative sources. There is no harmonised CLP classification (ECHA Annex VI) for reproductive toxicity for 'barley sh-oligopeptide-1', no SCCS or CIR safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenicity or endocrine disruption in PubMed. Peptides of this type are large biomolecules with low systemic absorption after topical application, so exposure is expected to be negligible for pregnancy.
Pregnancy-safe products containing barley sh-oligopeptide-1
Related ingredients
Frequently asked questions
- Безопасен ли barley sh-oligopeptide-1 при беременности?
- No evidence of reproductive or developmental hazard was identified in authoritative sources. There is no harmonised CLP classification (ECHA Annex VI) for reproductive toxicity for 'barley sh-oligopeptide-1', no SCCS or CIR safety assessment flagging reproductive risk, and no peer‑reviewed reports of teratogenicity or endocrine disruption in PubMed. Peptides of this type are large biomolecules with low systemic absorption after topical application, so exposure is expected to be negligible for pregnancy.
- Безопасен ли barley sh-oligopeptide-1 при грудном вскармливании?
- No data indicate reproductive or lactation hazards. No harmonised classification or authoritative safety assessment (CIR/SCCS) indicates risk to breastfeeding; no peer‑reviewed evidence shows milk transfer or effects on lactation. Topical peptides are unlikely to achieve systemic levels sufficient to transfer into breast milk.
- Безопасен ли barley sh-oligopeptide-1 для кожи малыша?
- No evidence of developmental or dermal toxicity in infants. Mechanistic concerns are not documented. However, infants (0–3 yr) have a higher skin permeability and higher surface‑area‑to‑weight ratio, so exposure potential is higher than in adults; adult dermal absorption for large oligopeptides is expected to be negligible, but given immature barrier function a conservative exposure score of 1 is applied. No infant‑specific adverse reports were found.
- Как VeriMom оценивает barley sh-oligopeptide-1?
- VeriMom оценивает barley sh-oligopeptide-1 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы barley sh-oligopeptide-1 при беременности?
- См. наш список безопасных альтернатив barley sh-oligopeptide-1 с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.